Ophthalmic Genetics and Gene Therapy


Gene therapy is a fast-paced method that controls genetic expression to treat disease. Often, through genetic therapy, genes are implanted in cells to reproduce protein production that may have been impaired due to a patient's DNA. These genes are usually presented with a vector designed to deliver genes to patients' cells. Ophthalmic genetics is a branch of ophthalmology that specializes in the field of research. Leber Congenital Amaurosis (LCA) is a genetic disorder that causes defects by birth in children. Scientists and doctors have treated the disease with the help of genetic engineering.



Genetics of Myopia Development



Gene Therapy



Usher syndrome



Familial exudative vitreous retinopathy



Retinoblastoma



Leber hereditary optic neuropathy (LHON)



Optic atrophy



Genetics of Myopia Development



 


  • Genetics of Myopia Development
  • Gene Therapy
  • Usher syndrome
  • Familial exudative vitreous retinopathy
  • Retinoblastoma
  • Leber hereditary optic neuropathy (LHON)
  • Optic atrophy
  • Genetics of Myopia Development

Related Conference of Ophthalmic Genetics and Gene Therapy

March 18-19, 2024

5th World Congress on Ophthalmology and Vision Science

Zurich, Switzerland
April 25-26, 2024

24th Global Ophthalmologists Annual Meeting

London, UK
May 09-10, 2024

7th International Eye and Vision Congress

Barcelona, Spain
May 16-17, 2024

8th World Congress on Eye and Vision

Rome, Italy
June 13-14, 2024

9th International Conference on Eye and Vision

Barcelona, Spain
October 10-11, 2024

34th World Congress on Ophthalmology and Optometry

Madrid, Spain
October 10-11, 2024

10th Global Ophthalmology Meeting

Madrid, Spain

Ophthalmic Genetics and Gene Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in